Karriereverlauf von K. Min
Ehemalige bekannte Positionen von K. Min
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| LONGEVERON INC. | Vorstandsvorsitzender | 01.06.2022 | 01.03.2023 |
| Technik-/Wissenschafts-/F&E-Leiter | 01.03.2023 | 30.06.2023 | |
Enterin, Inc.
 Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Technik-/Wissenschafts-/F&E-Leiter | - | 01.04.2021 |
| Bluerock Therapeutics, Inc. | Corporate Officer/Principal | - | - |
Ausbildung von K. Min
| Weill Cornell Medical College | Doctorate Degree |
| The Rockefeller University | Doctorate Degree |
| Harvard University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Doctorate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Executive Officer | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LONGEVERON INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Health Technology |
| Bluerock Therapeutics, Inc. |
